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The demonstration of the presence of dividing primitive cells
in damaged hearts has sparked increased interest about
myocardium regenerative processes. We examined the rate
and the differentiation of in vitro cultured resident cardiac
primitive cells obtained from pathological and normal
human hearts in order to evaluate the activation of progeni-
tors and precursors of cardiac cell lineages in post-ischemic
human hearts. The precursors and progenitors of cardiomy-
ocyte, smooth muscle and endothelial lineage were identi-
fied by immunocytochemistry and the expression of charac-
teristic markers was studied by western blot and RT-PCR. The
amount of proteins characteristic for cardiac cells (α-SA and
MHC, VEGFR-2 and FVIII, SMA for the precursors of car-
diomyocytes, endothelial and smooth muscle cells, respec-
tively) inclines toward an increase in both α-SA and MHC.
The increased levels of FVIII and VEGFR2 are statistically sig-
nificant, suggesting an important re-activation of neoangio-
genesis. At the same time, the augmented expression of
mRNA for Nkx 2.5, the trascriptional factor for cardiomyocyte
differentiation, confirms the persistence of differentiative
processes in terminally injured hearts.
Our study would appear to confirm the activation of human
heart regeneration potential in pathological conditions and
the ability of its primitive cells to maintain their proliferative
capability in vitro. The cardiac cell isolation method we used
could be useful in the future for studying modifications to the
microenvironment that positively influence cardiac primitive
cell differentiation or inhibit, or retard, the pathological
remodeling and functional degradation of the heart.
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R
ecently, the presence of dividing primitive
cells has been observed in organs considered
to be terminally differentiated, such as brain
(Uchida et al. 2000) and heart (Beltrami et al.
2001, 2003). Lineage negative, c-kit positive or
Sca-1 positive cells isolated from murine and dog
hearts have been demonstrated to produce car-
diomyocytes, smooth muscle and endothelial cells in
vitro (Rossi et al. 2005, Linke et al. 2005, Orlic et
al. 2001). Moreover, the precursors and progenitors
of all cardiac cell lineages have been identified on
the basis of the expression of specific markers: tran-
scription factors MEF-2C, GATA-6 and Ets-1 for
progenitors and the cytoplasmic proteins α-
Sarcomeric Actin (αSA) or myosin, Smooth Muscle
Actin (SMA) and Factor VIII (FVIII) for the pre-
cursors of cardiomyocytes, smooth muscle and
endothelial cells, respectively (Urbanek et al.
2005).
These observations have prompted studies focus-
ing on the regeneration of tissue damaged by dis-
eases (Urbanek et al. 2003) or the aging process
(Anversa et al. 2005), as the cardiac-resident prim-
itive cells seem to be a promising target for acute
and chronic heart disease therapy in which cardiac
regeneration may be accomplished by enhancing the
normal turnover of myocardial cells (Urbanek et al.
2005, Oh et al. 2003, Murry et al. 2004). On the
other hand, cardiomyocytes, smooth muscle cells,
endothelial cells and fibroblasts, being the more rep-
resentative of the cell populations in the myocardi-
um, are damaged in a different way after ischemia,
with fibroblasts in particular being involved in the
pathological remodeling of the injured heart leading
to the heart transplantation. At the same time,
recent studies have shown that myocytes prolifera-
tion in adult human hearts may be stimulated and
modulated by several factors (Postiglione et al.
2006, Urbanek et al. 2005).The present study was
designed to establish whether cardiac-resident
primitive cell populations exhibit different rate of
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differentiation in normal and in pathological
hearts.
Our objective was to evaluate the capability of the
human heart to induce an increase in the number of
resident cells able to differentiate in the cell lineag-
es that are functionally most important, in other
words cardiomyocytes, smooth muscle and endothe-
lial cells.To this end we established a method to iso-
late and co-culture the progenitors and precursors
of cardiac cell lineages from human biopsy speci-
mens. The quantification of cardiac primitive cells
of cardiomyocyte, smooth muscle and endothelial
lineage obtained from normal hearts and hearts
with post-ischemic cardiomyopathy was performed
in vitro, as was the observation of the expression
level of cytoplasmic proteins characteristic for the
differentiated cardiac cells. The technique of cell
culturing used in this study could well have an
impact on the study of the interactions between
cardiac cell populations.
Materials and Methods
Cell cultures
Cardiac primitive cells were isolated from bioptic
fragments (1,1-2,6 mm2) of the right ventricle of
normal and pathological human hearts. The first
were obtained from healthy donor hearts before
transplantation (n=10, ranging age 16-58, death
caused by thrauma or cerebral hemorrhage).
Similar biopsies were taken from the pathological
hearts within 4 hours of their explantation, as a
result of the terminal heart failure associated with
post-ischemic dilative cardiomyopathy (n=10, age
range 45-58, Left Ventricular Ejection Fraction
15-27%, NYHA class III/IV, duration of heart fail-
ure 5-13 years). All samples were obtained with the
informed consent of the patients in accordance with
the requirements of the hospital ethics committee.
The investigation conforms to the principles out-
lined in the Declaration of Helsinki.
All the tissue specimens were washed in the ster-
ile PBS solution and put on the glass-covered cul-
ture dishes in the F12K medium (Sigma-Aldrich,
St. Louis, USA) supplemented with 10% fetal
bovine serum and 5% horse serum (Invitrogen,
Carlsbad, USA), 5 ng/mL bFGF (Peprotech,
London, UK), 0,2 mM glutathione (Sigma-
Aldrich), Penicillin G 50000U and streptomycin 50
mg (Invitrogen). The outgrowth of cells from the
bioptic fragments was inspected at time periods
ranging from 2 to 4 weeks. Once the adherent cells
were more than 75% confluent, they were detached
with 0.25% trypsin-EDTA (Sigma-Aldrich): the
cover glasses and the bioptic fragments were then
removed and the cells were replated using a 1:4
dilution.
All morphological observations were performed
when the cells were replated for the first and the
third time (P1 and P3); biomolecular studies in
the form of western blot and RT-PCR were per-
formed at P3.
Growth kinetics
To determine in vitro growth kinetics of cells
derived from normal and pathological hearts, the
cells were seeded at the density of 2×103/cm2. The
cells were trypsinized and counted on a hemocy-
tometer after 2, 4, 6 and 8 days.
BrdU incorporation 
BrdU was added to each culture dish in the expo-
nential phase of the growth curve to give a final
concentration of 10 µM and incubated at 37°C for
1 hour. Detection of incorporated BrdU was per-
formed following the supplier’s protocol (Roche
Diagnostics GmbH, Germany). In brief, this
involved removing the medium and fixing the cells
with ethanol for 20 minutes at -20°C. The cells
were subsequently covered with anti-BrdU antibody
diluted 1:10 in incubation buffer and incubated for
30 minutes at 37°C then placed in anti-mouse-Ig-
fluorescein solution for a further 30 minutes at
37°C. The dishes were examined under a fluores-
cence microscope.
Immunocytochemistry
The cells were fixed with 4% paraformaldehyde at
room temperature for 20 minutes. They were then
covered for 30 minutes with 10% serum derived
from the species in which the secondary antibody
was raised, and subsequently incubated with primary
antibody for 60 minutes at 37°C.We used antibodies
against c-kit (Dako Cytomation, Glostrup,
Denmark), MDR-1, GATA-6, (Santa Cruz
Biotechnology, Santa Cruz, USA), α-SA, SMA,
FVIII, fibronectin (Sigma-Aldrich), ventricular
MHC (Chemicon, Temecula, USA) and VEGF-R2
(Flk-1/KDR, Novocastra, Newcastle, UK). After
PBS washes, rhodamine or fluorescein conjugated
anti-rabbit or anti-mouse IgG antibody was added to
the cells for 60 minutes at 37°C.The nuclei of cells
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were labeled with DAPI for 15 minutes at room tem-
perature before the final washes in PBS and were
then mounted in Vectashield. Signals were visualized
with a Leica DMLB fluorescent microscope.
Western blotting analysis
Protein extracts were prepared from the cultures
of cells derived from normal and pathological
hearts. In brief, the samples were incubated in a
lysis buffer (50 mM Tris-HCl pH 7,4, 250mM NaCl
and 0,1% Triton X-100) supplemented with pro-
teases inhibitors (leupeptin 10 µg/mL, pepstatin A
10 µg/mL, PMSF 0,4 mg/mL and EDTA 5 mg/mL)
for 30 minutes and centrifuged at 14,000 µg for 20
minutes. The BioRad Protein Assay was used to
determine the supernatant protein concentration.
Proteins (80 µg) were loaded on a 8% SDS-poli-
acrylamide gel. After electrophoresis, the proteins
were transferred onto nitrocellulose membrane by
semi-dry electro-blotting. The membranes were
blocked with 5% (w/v) non-fat milk for 3 hours and
incubated overnight in the blocking solution with
one of the following primary antibodies: α-SA
(Sigma-Aldrich), ventricular MHC (Chemicon),
ventricular MLC (Abcam, Cambridge, UK), VEGF-
R2 and FVIII (Sigma-Aldrich). After washing, the
membranes were probed with an HRP-labeled sec-
ondary IgG in 3% non-fat milk for 1 hour. Finally,
bands were visualized by chemiluminescence
(Amersham, Buckinghamshire, UK) followed by
autoradiography.
Semiquantitative RT-PCR
Total RNA was isolated by lysing the fresh cells
in Trizol solution (GIBCO BRL, Life Technologies,
Rockville, USA) according to the supplier’s proto-
col. The yield and integrity of each RNA sample
were checked by spectrophotometrical measure-
ment of A260 and agarose gel electrophoresis,
respectively. 5 mg of total RNA from each sample
were reverse-transcribed by using the First-Strand
cDNA Synthesis Kit (Amersham Pharmacia
Biotech, Arlington Heights, USA) according to the
protocol supplied by the manufacturer.The pd(N)6
primer provided in the kit was used.
The same volume (2-4 mL) of Reverse
Transcription Reaction from each sample was used
for subsequent PCR amplification with the primer
sets prepared for the target genes and the glycer-
aldehyde phosphate dehydrogenase (GAPDH)
housekeeping gene.
Samples without cDNA served as negative con-
trols for PCR amplifications.
The primers used for PCR and the expected size
of their amplification products are summarized in
Table 1 Specific primers for FVIII, Nkx2.5 and
GATA6 were designed with the assistance of Oligo4
software. Primers for GAPDH (Arcari et al. 1983)
were gently gifted by Prof. Arcari.
Primers for VEGFR 2 were designed according to
the literature (Enomoto et al. 2003).
The amplified products were analyzed by elec-
trophoresis in a 2% agarose gel containing ethidi-
um bromide, followed by photography under ultra-
violet illumination.
The levels of target cDNA were estimated by den-
sitometric scanning and normalized against
GAPDH loading controls. Densitometric analyses
of the PCR products were performed with NIH
Image software version 1.62F.
Statistical analysis
Summary values are given as the mean ± stan-
dard deviation of the mean.The unpaired Student´s
t-test was used for statistical analysis. Data were
considered to be statistically significant at a value
of p<0.05.
Results
Growth kinetics
Growth curves. Cells from pathological hearts
always showed a higher growth rate when com-
pared with cells from normal hearts. The increase
appeared more significant at P3, when the prolifer-
ation rhythm of cells from explanted hearts was ten
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Table 1. Oligonucleotides sequences used for semiquantitative RT-
PCR.
Target mRNA Primer Sequences PCR product (bp)
GAPDH Forward 5’-CACCATCTTCCAGGAGCGAG-3’ 371
Reverse 5’-TCACGCCACAGTTTCCCGGA-3’
GATA-6 Forward 5’-GCCCCTCATCAAGCCGCAGAA-3’ 378
Reverse 5’-TCTCCCGCACCAGTCATCACC-3’
VEGFR-2 Forward 5’-GATGTGGTTCTGAGTCCGTCT-3’ 560
Reverse 5’-CATGGCTCTGCTTCTCCTTTG-3’
FVIII Forward 5’-CAGCCTCTACATCTCTCAGTT-3’ 210
Reverse 5’-ATGCGAAGAGTGCTGCGAATG-3’
Nkx 2.5 Forward 5’-CCTCAACAGCTCCCTGAC-3’ 169
Reverse 5’-CTCATTGCACGCTGCATA-3’
times higher than that of normal cells (Figure 1).
BrdU assays. Quantitative determination of DNA
synthesis made by BrdU showed a significant
increase of newly synthesized DNA in cell cultures
from post-ischemic hearts over that of cell cultures
from normal hearts, with a progressive decrease
depending on the culture passages (Table 2).
Characterization of the cultured cells
Morphology and number of primitive, progenitor
and precursor cells: immunocytochemistry.
Immunodetection at culture passages P1 and P3
showed that cells derived from bioptic pieces of
normal and pathological hearts had membrane,
cytoplasmic and nuclear antigens characteristic for
the primitive cells of cardiac lineages (cardiomy-
ocytes, endothelial and smooth muscle cells, fibrob-
lasts).The cell percentage was determined by three
independent observers by counting 30 fields in
every culture dish. The number of cells that
expressed one of the cited markers was then com-
pared with the number of cell nuclei (Table 3).The
immunopositivity for the different markers of car-
diac primitive cells is shown in Figure 2.
Western Blotting. The protein characteristics for
the particular populations of primitive cells derived
from normal and pathological hearts were quanti-
fied by western blot. The expression of α-SA was
1.9 times higher in the cells of the hearts with post-
ischemic cardiomyopathy. Similarly, MHC was
expressed more strongly in these cells (1.3-fold
increase). The expression of FVIII and VEGFR-2
was increased by 1.5 and 17 times higher, respec-
tively (Figure 3).
RT-PCR. Using RT-PCR to quantifying the mRNA
for the proteins investigated substantially con-
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Table 3. Immunocytochemical characterization of cells in vitro (%).
Marker positivity Cell lineage From normal hearts From post-ischemic hearts
P1 P3 P1 P3
c-kit/mdr-1 Primitive cells 1,85±0,12 1,77±0,1 0,62±0,04 0,58±0,03
α−SA/MHC Cardiomyocytes 4,93±0,2 4,94±0,4 15,82±1,4 11,45±1,0
FVIII Endothelial cells 2,6±0,15 1,3±0,09 4±0,2 4,7±0,3
SMA/GATA6 Smooth muscle cells 3,87±0,3 3,77±0,32 10,7±1,0 4,9±0,3
Fibronectin Fibroblasts 86,75±8,0 88,2±7,9 68,86±6,7 78,37±7,5
Table 2. BrdU incorporation in vitro (% of positive cells).
P1 P3
From normal hearts 29,4±0,5 25,9±0,8 
From pathological hearts 35,1±0,9 30,6±0,5
Figure 1. Cell growth rate at the first (P1) and the third (P3) in
vitro passages. Pathological hearts cells always showed higher
growth rates than cells from normal hearts. 
279
Original Paper
Figure 2. Immunopositivity for different markers of cardiac primitive cultured cells. Primitive cells in A are c-kit and MDR-1 positive.
In B, cardiomyocytes precursors are stained by a-sarcomeric actin and MHC antibodies; in C VEGFR-2 and factor VIII immunopositivi-
ty stain the endothelial cells. Magnification 20X (A left), 40X (B left and right, C left), 100X (A and C right).
firmed the increased number of precursors for
endothelial cells, cardiomyocytes and smooth mus-
cle cells in the cultures from pathologic hearts, with
a light but constant increase in the expression of
mRNA for Nkx2.5 and GATA-6, suggesting a neo-
differentiation of the cardiomyocytes and smooth
muscle cells precursors, and a marked increase in
mRNA expression for VEGFR2, in the cells from
explanted hearts as compared to the cells from nor-
mal hearts, which indicates neo-angiogenesis
(Figure 4).
Discussion
The cell cultures obtained from the bioptic frag-
ments of normal hearts and from the pathological
hearts with post-ischemic cardiomyopathy con-
tained, as expected, a small number of stem cells, a
relatively larger population of cardiac progenitors
and precursors, and an extremely high population
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Figure 3. The expression of protein characteristic for lineage
committed cardiac primitive cells in vitro was evaluated by
western blot analysis of equal amounts of proteins in whole cell
lysates. The results are shown as an increase of densitometric
value for pathological cells normalized to normal cells. Values
are means ± SD; n = 10. *p<0,05.
Figure 4. mRNA expression of specific markers of cardiac cell
lineages in precursors and progenitors. A, Representative RT-
PCR results for FVIII, VEGFR2, Nkx2.5 and GATA-6 are shown.
B, The relative expression of FVIII, VEGFR2, Nkx2.5 and GATA-
6 was quantified from ten independent experiments, and the
mean ± SD is presented for each marker. *p<0,05.
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of myofibroblasts. Of all these cells, the last group
represents the cells with the highest proliferation
potential.
It is well known that primitive cells represent only
small fraction of the cells in any tissue. The fre-
quency of hematopoietic stem cells has been esti-
mated as being between one per 10.000 and one
per 100.000 in bone marrow cells (Conti et al.
2005). In the mouse heart the number of the c-kit
positive cells varies from 10 to 85 in 100 mm2
(Beltrami et al. 2001). Their main role is to give
rise to rapidly proliferating and migrating progeni-
tors and precursors of cells of different lineages
that, ultimately, undergo differentiation while
retaining the capability of self-renewal. This
requires a balance between the asymmetric mode
of division and both the symmetrical self- renewing
and commitment divisions. The mechanisms con-
trolling their cell cycles are not well known. Many
studies indicate genes and proteins responsible for
the fate of stem cells are at work here, in vivo.
However, these processes depend on specialized cel-
lular microenvironments and the in vitro expansion
of pure populations of adult stem cells remains elu-
sive (Oh et al. 2003). For these reasons, it is not
surprising that, in our study, the bioptic fragments
of cardiac tissue 1,1-2,6 mm2 in size only enabled
the outgrowth of a few lineage negative, c-kit posi-
tive stem cells. From this point of view, our study of
the histological sections performed on the speci-
mens (data not shown) confirmed the conclusions
drawn by other authors in their in vivo investiga-
tions of the hypertrophied myocardium of patients
with chronic aortic stenosis, which showed the
growth and differentiation of cardiac stem cells in
mature myocytes as markedly enhanced in patho-
logical tissue fragments (Urbanek et al. 2003).
Also worth noticing is the increase in the relative
number of cardiac precursors and progenitors iso-
lated from the explanted human hearts with chron-
ic post-ischemic cardiomyopathy in vitro (our per-
centage results indicate a four-fold increase in α-
SA expressing cells and an almost two-fold increase
in endothelial cells). This reflects an activation of
the regeneration potential of the human heart
under pathological conditions and the continuation
of this activation even during in vitro culturing.
Moreover, although there is no direct evidence that
cardiac progenitor doubling is primarily involved in
the observed increase in cell proliferation, we feel it
is important to report the indirect evidence that the
decrease in fibronectin positive cells observed in
post-ischemic hearts is statistically significant
(Table 3).
We observed that the growth rate of cardiac cell
populations in vitro was always higher in cultures
from explanted hearts; this is not really surprising,
because fibroblasts are the more representative cell
population in our co-cultures and are activated by
the disease. As regards the expression of proteins
characteristic for cardiac cells (α-SA and MHC,
VEGFR-2 and FVIII, SMA for the precursors of
cardiomyocytes, endothelial and smooth muscle
cells, respectively) there is a trend towards an
increase in both α-SA and MHC, while the
increased levels of FVIII and VEGFR2 are statisti-
cally significant.
This trend offers food for thought, as it implies an
important re-activation of neoangiogenesis; on the
other hand, the increased expression of mRNA for
Nkx 2.5, the trascriptional factor for cardiomyocyte
differentiation, also suggests the persistence of dif-
ferentiative processes in terminally injured hearts.
In this study, the in vitro rate of activation and
differentiation of cardiac primitive cells was meas-
ured using specimens of human hearts in two
extreme conditions: those with no sign of cardiovas-
cular disease and other manifesting the cardiomy-
opathy associated with a terminal insufficiency,
where only heart transplantation can save the life
of the patient. It is not known at what time during
the development of heart failure this activation
occurs, or when the primitive cells’ capacity for pro-
ducing committed progenies and conserving the
self-renewal properties is finally at an end resulting
in the exhaustion of their pool in the heart.
The evidence that in vitro cultured cells from
pathological hearts show a higher number of car-
diac lineages positive cells than the cultures
obtained from normal hearts confirms their activa-
tion in response to the pathological conditions dur-
ing the progress of a disease. Further investigation
is required in order to determine whether this acti-
vation, which does not cease even after all the
remodeling of the heart or with the gradual wors-
ening of its function during ischemic heart disease,
leads to the depletion of the cardiac stem cell pool.
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